January 2020

Per recent study, patients with B-cell NHL (non-Hodgkins Lymphoma) who failed to respond to prior treatment therapies show positive results when given mosunetuzumab, a new investigational drug. This new drug targets two proteins, one on the surface of tumor cells and the other on the surface of the recipient’s T cells. The study has been...

Black men are nearly 2.5 times more likely to be diagnosed with and die of prostate cancer compared to non-Hispanic white men.  A new study aims to debunk the long-held belief that this is due to genetic factors. JAMA Oncology’s research team led by the U-M Rogel Cancer Center analyzed data from more than 300,000...

A new study has found that Type 2 diabetes in black patients is driven by a different mechanism than the the conventional concept of visceral fat deposition generating insulin resistance, as largely determined by research history in the white European population.  The results imply that Black patients have a very different reason for developing Type...

A new bombshell research paper conducted by a team of fellows in CIFAR’s Humans and the Microbiome is reporting that long known non-communicable diseases including heart disease, cancer and lung disease possibly can, in fact, be passed along to others through airborne contact.  “If our hypothesis is proven correct, it will rewrite the entire book...

Cellular immunotherapy is an innovative treatment approach that harnesses the body’s own immune system to fight cancer. These novel treatments are helping to transform the landscape for many current and future cancer patients.  Preclinical studies provide the first evidence that cellular immunotherapy for B cell cancers could ultimately become an off-the-shelf product, capable of being...

Multiple myeloma is a form of cancer that forms in a type of white blood cell called a plasma cell. Plasma cells help fight infections by making antibodies that recognize and attack germs.    Multiple myeloma causes cancer cells to accumulate in the bone marrow, where they crowd out healthy blood cells.  Researchers found that...

More than three out of four patients with multiple myeloma that had unsuccessful therapy have been found to remain in remission more than seven months after treatment with a CAR T-cell therapy targeting two proteins that are frequently found on myeloma cells. Those experiencing sustained remissions include nine patients with a difficult-to-treat form of multiple...

According to a study published in the July edition of the Neurology journal in 2007, multiple sclerosis affects the immune systems of African-Americans and whites differently.  The study, pointed out that multiple sclerosis (MS) is not as prevalent but often more severe in Black people than in whites. The exact reason still hasn’t been identified,...

In a groundbreaking study in the 1990s, researchers stated that herpesvirus 6 (HHV6)—could be somehow involved in the development of multiple sclerosis.  However, upon further research, those claims were disproven due to HHV6 turning out to be two related, but distinct variants—HHV6A and HHV6B. Because the two viruses are similar, during the 90s and early,...